We are live on ! Find out more
TTPH

Tetraphase Pharmaceuticals, Inc.
TTPH

Delisted

TTPH was delisted on the 28th of July, 2020.

Back to rankings

41 hedge funds and large institutions have $56.8M invested in Tetraphase Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$15.1M +$17M +107,082 New
BC
2
Broadfin Capital
New York
$10M +$11.3M +71,416 New
Jennison Associates
3
Jennison Associates
New York
$6.41M +$7.22M +45,575 New
AWMDMG
4
Austin W. Marxe & David M. Greenhouse
New York
$6.33M +$7.13M +45,000 New
DM
5
Deerfield Management
New York
$3.9M +$4.39M +27,745 New
BCPEM
6
Bain Capital Public Equity Management
Massachusetts
$2.58M +$2.91M +18,376 New
PRCM
7
Pine River Capital Management
Minnesota
$2.56M +$2.88M +18,183 New
BFA
8
BlackRock Fund Advisors
California
$2.05M +$2.31M +14,578 New
BIT
9
BlackRock Institutional Trust
California
$1.57M +$1.77M +11,198 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$946K +$1.07M +6,731 New
FCM
11
Farallon Capital Management
California
$780K +$878K +5,547 New
Morgan Stanley
12
Morgan Stanley
New York
$570K +$642K +4,055 New
CS
13
Credit Suisse
Switzerland
$488K +$550K +3,471 New
TCIM
14
TIAA CREF Investment Management
New York
$313K +$352K +2,224 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$291K +$328K +2,070 New
BA
16
BlackRock Advisors
Delaware
$290K +$326K +2,061 New
GC
17
Guggenheim Capital
Illinois
$270K +$304K +1,918 New
Northern Trust
18
Northern Trust
Illinois
$241K +$272K +1,716 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$230K +$259K +1,638 New
UOC
20
UBS O'Connor
Illinois
$218K +$245K +1,550 New
BIM
21
BlackRock Investment Management
Delaware
$200K +$225K +1,421 New
State Street
22
State Street
Massachusetts
$164K +$184K +1,160 New
PAM
23
Panagora Asset Management
Massachusetts
$146K +$165K +1,039 New
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$141K +$159K +1,004 New
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$128K +$144K +909 New
1
2

TTPH Hedge Fund Activity: Q2 2013 in Review

41 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q2 2013, worth a combined $56.8M.

Buyers outnumbered sellers: 41 funds opened new TTPH positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

  • 41 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $56.8M of Tetraphase Pharmaceuticals, Inc. stock for Q2 2013.
  • 41 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +41 holders.

Based on aggregated 13F filings for Q2 2013.